A498 and 786-O are well established ccRCC tumor cell lines, historically used in many studies of VEGFR directed therapy in immunodeficient mice since there is no syngeneic mouse model of kidney cancer that recapitulates the biology of human ccRCC. This evidence concerns the gene KDR and nonpapillary renal cell carcinoma.